AIM: To investigate three isoforms of survivin in colorectal adenocarcinomas. METHODS: We used the LightCycler Technology (Roche), along with a common forward primer and reverse primers specific for the splice variants and two common hybridization probes labeled with fluorescein and LightCycler-Red fluorophore (LC-Red 640). Real time quantitative polymerase chain reaction (PCR) was performed on cDNAs from 52 tumor specimens from colorectal cancer patients and 10 unrelated normal colorectal tissues. In the patients group, carcinoembryonic antigen (CEA) and CA19-9 tumor markers were also measured immunochemically. RESULTS: Wild type survivin mRNA isoform was expressed in 48% of the 52 tumor samples, survivin-2b in 38% and survivin-ΔΕx3 in 29%, while no expression was found in normal tissues. The mRNA expression of wild type survivin presented a significant correlation with the expression of the ratio of survivin-2b, survivin-ΔΕx3, survivin-2b/wild type survivin and survivin-ΔΕx3/wild type survivin (P < 0.001). The mRNA expression of wild-survivin and survivin-ΔΕx3 was related with tumor size and invasion (P = 0.006 and P < 0.005, respectively). A significant difference was found between survivin-2b and morphologic cancer type. Also, the ratio of survivin-ΔEx3/wild-survivin was significantly associated with prognosis. No association was observed between the three isoforms and grade, metastasis, Dukes stage and gender. The three isoforms were not correlated with CEA and CA19-9. CONCLUSION: Survivin isoforms may play a role in cell apoptosis and their quantification could provide information about clinical management of patients suffering from colorectal cancer.
AIM: To investigate three isoforms of survivin in colorectal adenocarcinomas. METHODS: We used the LightCycler Technology (Roche), along with a common forward primer and reverse primers specific for the splice variants and two common hybridization probes labeled with fluorescein and LightCycler-Red fluorophore (LC-Red 640). Real time quantitative polymerase chain reaction (PCR) was performed on cDNAs from 52 tumor specimens from colorectal cancerpatients and 10 unrelated normal colorectal tissues. In the patients group, carcinoembryonic antigen (CEA) and CA19-9tumor markers were also measured immunochemically. RESULTS: Wild type survivin mRNA isoform was expressed in 48% of the 52 tumor samples, survivin-2b in 38% and survivin-ΔΕx3 in 29%, while no expression was found in normal tissues. The mRNA expression of wild type survivin presented a significant correlation with the expression of the ratio of survivin-2b, survivin-ΔΕx3, survivin-2b/wild type survivin and survivin-ΔΕx3/wild type survivin (P < 0.001). The mRNA expression of wild-survivin and survivin-ΔΕx3 was related with tumor size and invasion (P = 0.006 and P < 0.005, respectively). A significant difference was found between survivin-2b and morphologic cancer type. Also, the ratio of survivin-ΔEx3/wild-survivin was significantly associated with prognosis. No association was observed between the three isoforms and grade, metastasis, Dukes stage and gender. The three isoforms were not correlated with CEA and CA19-9. CONCLUSION: Survivin isoforms may play a role in cell apoptosis and their quantification could provide information about clinical management of patients suffering from colorectal cancer.
Entities:
Keywords:
Apoptosis gene; Colorectal adenocarcinomas; Lightcycler; Real time quantitative polymerase chain reaction; Survivin; mRNA isoforms
Authors: Hugo Caldas; Yuying Jiang; Michael P Holloway; Jason Fangusaro; Csaba Mahotka; Edward M Conway; Rachel A Altura Journal: Oncogene Date: 2005-03-17 Impact factor: 9.867
Authors: Rosalia de Necochea-Campion; Chien-Shing Chen; Saied Mirshahidi; Frank D Howard; Nathan R Wall Journal: Cancer Lett Date: 2013-06-18 Impact factor: 8.679
Authors: Y de Jong; J G van Oosterwijk; A B Kruisselbrink; I H Briaire-de Bruijn; G Agrogiannis; Z Baranski; A H G Cleven; A-M Cleton-Jansen; B van de Water; E H J Danen; J V M G Bovée Journal: Oncogenesis Date: 2016-05-09 Impact factor: 7.485
Authors: Marieke A de Graaff; Shruti Malu; Irma Guardiola; Alwine B Kruisselbrink; Yvonne de Jong; Willem E Corver; H Gelderblom; Patrick Hwu; Torsten O Nielsen; Alexander J Lazar; Neeta Somaiah; Judith V M G Bovée Journal: Transl Oncol Date: 2017-06-24 Impact factor: 4.243
Authors: Tien-Jui Tsang; Ying-Chang Hsueh; Erika I Wei; David J Lundy; Bill Cheng; You-Tzung Chen; Shoei-Shen Wang; Patrick C H Hsieh Journal: Theranostics Date: 2017-10-13 Impact factor: 11.556